Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anti-inflammatory protein pathways are molecular signaling routes and mechanisms by which specific proteins and peptides suppress or resolve inflammation in tissues. These pathways are crucial for maintaining immune homeostasis, preventing excessive tissue damage, and resolving inflammatory responses after infection or injury. Key pathways involved include NF-κB, MAPK, cAMP signaling, and Keap1/Nrf2/ARE. They function by downregulating proinflammatory cytokine production, upregulating anti‑inflammatory mediators, limiting leukocyte recruitment/migration, and promoting the resolution phase of inflammation. Dysregulation of these pathways contributes to various inflammatory diseases, making them therapeutic targets for biologics and small molecules.
Modulation of NF-κB, MAPK, cAMP, and Nrf2/ARE pathways to suppress inflammation and promote tissue repair.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-inflammatory Protein Pathways (None).